Cinemark Holdings, Inc.

CNK · NYSE

Market closed$30.42$0.570000 (+1.91%)After hours $30.66 · +0.79%

Key statistics

Previous close$29.85
Open$29.90
Day high$30.58
Day low$29.65
52-week high$34.73
52-week low$21.60
Market cap3.55B
Volume2.45M
Average volume2.26M
P/E ratio26.92
Forward P/E
EPS1.13
Dividend yield+1.15%

Market context

Why it moved

Cinemark (CNK) shares moved higher amid positive sector sentiment for movie theater stocks, likely buoyed by encouraging box office trends and a broader recovery narrative for cinema attendance, even as competitor AMC continues to trade at deep discounts reflecting the contrasting financial health between the two exhibitors.

What is happening

Recent company-specific developments and publisher coverage.

July 18, 2026Cinemark closed higher despite a Wells Fargo downgrade from Overweight to Equal Weight with a trimmed price target of $31, citing an anticipated Q3 box office 'air pocket' in the film release schedule. B. Riley also cut its price target from $36 to $35 while maintaining a Neutral rating. Still, the stock gained nearly 2%, buoyed by Roth Capital reiterating a Buy with a $38 target and Benchmark maintaining a Buy at $37. Investors are also eyeing the Q2 2026 earnings call scheduled for July 30, with the company having reported record May and June box office results as recent tailwinds.

1.9095

July 17, 2026Cinemark Holdings closed essentially flat despite a notable analyst headwind, as Wells Fargo downgraded the stock from Overweight to Equal-Weight and cut its price target from $36 to $31, citing an 'air pocket' in the Q3 film release schedule and trimming its box office forecast to $9.9B. The downgrade tempered what had been a broadly constructive setup heading into Q2 earnings — scheduled for July 30 — following Cinemark's record May and June domestic box office performance, a recent Goldman Sachs upgrade to Neutral, and CNK crossing above its 200-day moving average just the prior session. Broader markets also dipped as tech-led selling weighed on the Communication Services sector (XLC).

0.067

July 16, 2026Cinemark Holdings closed higher, gaining roughly 1.6%, as bullish analyst sentiment and a key technical milestone drew investor attention. Shares crossed above their 200-day moving average intraday, a signal watched closely by technical traders, while Barrington analyst Patrick Sholl maintained a Buy rating with a $36 price target. The backdrop remains favorable for theater operators — Q2 2026 was the best second quarter at the domestic box office since 2019 — and Cinemark's comparatively clean balance sheet continues to differentiate it from peer AMC, generating over $2.50 of adjusted EBITDA for every $1 of interest expense. Consensus analyst rating stands at Moderate Buy with an average price target of $35, implying meaningful upside from current levels.

1.5662

July 15, 2026Cinemark Holdings edged higher, outperforming AMC Entertainment and the broader Communication Services sector (XLC essentially flat in after-hours), as a cooler-than-expected June CPI report lifted market sentiment and underscored the theater operator's financial edge over peers. A recent comparison highlighted CNK's superior EBITDA efficiency — generating roughly $2.55 of adjusted EBITDA per dollar of interest expense versus AMC's inverted ratio — reinforcing Cinemark's standing as the stronger-balance-sheet operator in the exhibition space. Analysts continue to debate the stock's upside amid a strong 2026 film slate, with Spider-Man and Avengers among the tentpoles expected to push box office revenues above $10B for the first time since COVID.

0.7547

July 14, 2026Cinemark Holdings edged up modestly, holding steady against a challenging macro backdrop as U.S.-Iran hostilities rattled broader markets and weighed on discretionary names. The key narrative for investors centers on Goldman Sachs upgrading CNK to Neutral from Sell on July 8th with a $30 price target, while JPMorgan trimmed its 2026 North America box office forecast to $9.65B citing a slow Q3 start — lowering estimates for Cinemark ahead of earnings — even as Q2 box office hit a post-pandemic high of $2.97B, up 12% year-over-year.

0.3788

July 10, 2026Cinemark closed modestly lower, edging down less than 0.5%, as a Goldman Sachs upgrade from Sell to Neutral — with the price target lifted to $30 from $23 — provided a meaningful sentiment boost that was largely offset by the stock trading near that newly raised target. The upgrade, which cited Cinemark's execution in market share, pricing discipline, and premium format growth, coincided with broad industry tailwinds after Q2 2026 domestic box office receipts hit roughly $2.97 billion, the strongest second quarter since 2019, reinforcing the theater recovery thesis despite lingering concerns about elevated debt and content volatility.

-0.4706

July 9, 2026Cinemark Holdings closed modestly higher, recouping a portion of the prior session's 5% decline, as strong Q2 box office data reinvigorated investor sentiment toward theater stocks. AMC's CEO highlighted that Q2 2026 domestic box office reached ~$2.97 billion — the best second quarter since 2019 and one of the top five quarterly totals in 50 years — while Macquarie maintained its Outperform rating on Cinemark and raised its price target to $38, citing the company's healthy balance sheet and ability to convert rising attendance into improved profitability. The gains came despite a broader market risk-off move tied to escalating U.S.-Iran tensions and surging oil prices, headwinds that weighed on travel-adjacent names but left Cinemark relatively resilient.

1.1217

July 8, 2026Cinemark Holdings fell nearly 2%, extending a rough stretch for theater stocks after peer AMC Entertainment dropped ~8% the prior session on dilutive share offerings, dragging the exhibition group lower. The selloff comes despite a constructive fundamental backdrop — Benchmark recently raised its price target to $37 (Buy) citing Cinemark's strong Q1 results (revenue +19% YoY) and improving Q2 trends fueled by surprise breakout films and a favorable genre mix. With the stock down ~8% over the past week but still up ~30% year-to-date, investors appear to be trimming gains amid sector-wide pressure and broader market weakness led by semiconductor declines.

-1.7696

Simply Wall Street · July 18, 2026Cinemark Holdings (CNK) Sets Q2 Update On A Narrative That Still Looks UndervaluedSeeking Alpha · July 16, 2026Cinemark and IMAX are cut at Wells Fargo due to an 'air pocket' in the film release schedule (CNK:NYSE)Stock Titan · July 16, 2026Cinemark Will Webcast Q2 Results at 8:30 a.m. ET July 30Ad-hoc-news.de · July 8, 2026Cinemark Holdings finds its footing as theater traffic stabilizes. CNK stock reflects a cautious recStock Titan · June 1, 2026Cinemark’s biggest May at the box office — and at the snack barSimply Wall Street · May 28, 2026Helix Exit From Cinemark Raises Questions On Institutional Sentiment And ValueThe Hollywood Reporter · May 1, 2026Cinemark Shrinks First Quarter Loss on Higher Attendance, RevenuesBusiness Wire · May 1, 2026Cinemark Holdings, Inc. Reports First Quarter 2026 Earnings Results
Mt Newswire · July 17, 2026B. Riley Trims Price Target on Cinemark to $35 From $36, Maintains Neutral Rating
Mt Newswire · July 16, 2026Wells Fargo Downgrades Cinemark to Equalweight From Overweight, Adjusts Price Target to $31 From $36
Mt Newswire · July 9, 2026Goldman Sachs Upgrades Cinemark to Neutral From Sell, Raises Price Target to $30 From $23
Benzinga · July 9, 2026Goldman Sachs Upgrades Cinemark Holdings to Neutral, Raises Price Target to $30
Benzinga · July 8, 2026Macquarie Maintains Outperform on Cinemark Holdings, Raises Price Target to $38
Mt Newswire · June 30, 2026June Domestic Box Office Likely to Set Up Best Second-Quarter Post COVID-19, B. Riley Says
Benzinga · June 17, 2026Benchmark Maintains Buy on Cinemark Holdings, Raises Price Target to $37
Benzinga · June 11, 2026B. Riley Securities Maintains Neutral on Cinemark Holdings, Raises Price Target to $36

Peers